Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
68.87
+0.04 (0.06%)
At close: Dec 10, 2025, 4:00 PM EST
67.97
-0.90 (-1.31%)
After-hours: Dec 10, 2025, 7:39 PM EST
Arrowhead Pharmaceuticals Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$57.90
Upside
-15.93%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $62 → $81 | Strong Buy | Maintains | $62 → $81 | +17.61% | Dec 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $80 → $85 | Strong Buy | Maintains | $80 → $85 | +23.42% | Dec 2, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $42 → $62 | Strong Buy | Maintains | $42 → $62 | -9.98% | Dec 1, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $60 | Strong Buy | Maintains | $60 | -12.88% | Dec 1, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $45 → $48 | Hold | Maintains | $45 → $48 | -30.30% | Nov 26, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $27 → $48 | Hold | Maintains | $27 → $48 | -30.30% | Nov 20, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $45 → $52 | Buy | Maintains | $45 → $52 | -24.50% | Nov 19, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $60 | Strong Buy | Maintains | $60 | -12.88% | Nov 19, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $45 → $70 | Buy | Maintains | $45 → $70 | +1.64% | Nov 19, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $29 → $45 | Hold | Maintains | $29 → $45 | -34.66% | Nov 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +16.16% | Oct 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +16.16% | Sep 2, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $60 | Strong Buy | Maintains | $60 | -12.88% | Aug 11, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $40 → $38 | Buy | Maintains | $40 → $38 | -44.82% | Aug 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +16.16% | May 20, 2025 |
| Citigroup | Citigroup | Hold Maintains $21 → $17 | Hold | Maintains | $21 → $17 | -75.32% | May 13, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.